Hossen F, Sun G, Lee J
Free Radic Biol Med. 2024; 221:261-272.
PMID: 38815773
PMC: 11184584.
DOI: 10.1016/j.freeradbiomed.2024.05.044.
Mroczek K, Fernando S, Fisher P, Annesley S
Front Cell Dev Biol. 2021; 9:741662.
PMID: 34552934
PMC: 8450459.
DOI: 10.3389/fcell.2021.741662.
Sierra-Fonseca J, Rodriguez M, Themann A, Lira O, Flores-Ramirez F, Vargas-Medrano J
J Alzheimers Dis. 2021; 83(4):1691-1702.
PMID: 34420960
PMC: 8890332.
DOI: 10.3233/JAD-210475.
Tai C, Chang C, Yu G, Lopez I, Yu X, Wang X
Neuron. 2020; 106(3):421-437.e11.
PMID: 32126198
PMC: 7210056.
DOI: 10.1016/j.neuron.2020.01.038.
Gamache J, Kemper L, Steuer E, Leinonen-Wright K, Choquette J, Hlynialuk C
J Neurosci. 2019; 40(1):220-236.
PMID: 31685653
PMC: 6939485.
DOI: 10.1523/JNEUROSCI.1256-19.2019.
Aggregate Interactome Based on Protein Cross-linking Interfaces Predicts Drug Targets to Limit Aggregation in Neurodegenerative Diseases.
Balasubramaniam M, Ayyadevara S, Ganne A, Kakraba S, Penthala N, Du X
iScience. 2019; 20:248-264.
PMID: 31593839
PMC: 6817627.
DOI: 10.1016/j.isci.2019.09.026.
could improve hippocampal tau protein and TNF levels and cognitive behavior defects in a rat model of Alzheimer's disease.
Ahmadi M, Taherianfard M, Shomali T
Avicenna J Phytomed. 2019; 9(5):465-473.
PMID: 31516860
PMC: 6727437.
High specificity of widely used phospho-tau antibodies validated using a quantitative whole-cell based assay.
Li D, Cho Y
J Neurochem. 2019; 152(1):122-135.
PMID: 31325178
PMC: 6928439.
DOI: 10.1111/jnc.14830.
Anti-Neuroinflammatory Property of Phlorotannins from on Aβ-Induced Damage in PC12 Cells.
Lee S, Youn K, Kim D, Ahn M, Yoon E, Kim O
Mar Drugs. 2018; 17(1).
PMID: 30583515
PMC: 6356621.
DOI: 10.3390/md17010007.
Neuroprotective effects of tenuigenin on neurobehavior, oxidative stress, and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats.
Huang X, Chen Y, Chen W, Wang N, Wu X, Liu Y
Brain Circ. 2018; 4(1):24-32.
PMID: 30276333
PMC: 6057698.
DOI: 10.4103/bc.bc_2_17.
A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's Disease.
Khan R, Nirzhor S, Rashid B
Brain Sci. 2018; 8(9).
PMID: 30149687
PMC: 6162660.
DOI: 10.3390/brainsci8090162.
Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?.
Laurent C, Buee L, Blum D
Biomed J. 2018; 41(1):21-33.
PMID: 29673549
PMC: 6138617.
DOI: 10.1016/j.bj.2018.01.003.
Nature of Tau-Associated Neurodegeneration and the Molecular Mechanisms.
Yang Y, Wang J
J Alzheimers Dis. 2018; 62(3):1305-1317.
PMID: 29562535
PMC: 5870018.
DOI: 10.3233/JAD-170788.
Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells.
Ren Q, Wang Y, Gong W, Zhou Q, Xu L, Zhang Z
J Mol Neurosci. 2015; 56(2):500-8.
PMID: 25687330
DOI: 10.1007/s12031-015-0519-4.
Therapeutic and diagnostic challenges for frontotemporal dementia.
Dalton S, Lewis J
Front Aging Neurosci. 2014; 6:204.
PMID: 25191265
PMC: 4137452.
DOI: 10.3389/fnagi.2014.00204.
Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer's disease.
Wang J, Wang Z, Tian Q
Neurosci Bull. 2014; 30(2):359-66.
PMID: 24627329
PMC: 5562660.
DOI: 10.1007/s12264-013-1415-y.
PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.
Dumont M, Stack C, Elipenahli C, Jainuddin S, Launay N, Gerges M
FASEB J. 2014; 28(4):1745-55.
PMID: 24398293
PMC: 3963016.
DOI: 10.1096/fj.13-236331.
Overexpression of 14-3-3z promotes tau phosphorylation at Ser262 and accelerates proteosomal degradation of synaptophysin in rat primary hippocampal neurons.
Qureshi H, Han D, MacDonald R, Paudel H
PLoS One. 2013; 8(12):e84615.
PMID: 24367683
PMC: 3868614.
DOI: 10.1371/journal.pone.0084615.
Tau phosphorylation and μ-calpain activation mediate the dexamethasone-induced inhibition on the insulin-stimulated Akt phosphorylation.
Liu Y, Su Y, Sun S, Wang T, Qiao X, Run X
PLoS One. 2012; 7(4):e35783.
PMID: 22536436
PMC: 3335002.
DOI: 10.1371/journal.pone.0035783.
Human tau may modify glucocorticoids-mediated regulation of cAMP-dependent kinase and phosphorylated cAMP response element binding protein.
Liu Y, Su Y, Sun S, Wang T, Qiao X, Li H
Neurochem Res. 2012; 37(5):935-47.
PMID: 22294156
DOI: 10.1007/s11064-011-0686-9.